A detailed history of Ameritas Investment Partners, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 26,094 shares of PACB stock, worth $50,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,094
Previous 26,094 -0.0%
Holding current value
$50,883
Previous $35,000 25.71%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $6,262 - $10,867
1,049 Added 4.19%
26,094 $255,000
Q3 2023

Nov 13, 2023

BUY
$8.23 - $13.93 $34,804 - $58,909
4,229 Added 20.32%
25,045 $209,000
Q2 2023

Aug 11, 2023

BUY
$9.97 - $14.05 $9,222 - $12,996
925 Added 4.65%
20,816 $276,000
Q1 2023

May 10, 2023

BUY
$7.94 - $12.02 $14,419 - $21,828
1,816 Added 10.05%
19,891 $230,000
Q4 2022

Feb 13, 2023

BUY
$5.67 - $11.2 $6,429 - $12,700
1,134 Added 6.69%
18,075 $147,000
Q2 2022

Aug 12, 2022

BUY
$4.02 - $10.43 $8,172 - $21,204
2,033 Added 13.64%
16,941 $74,000
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $12,255 - $17,264
-493 Reduced 3.2%
14,908 $381,000
Q2 2021

Aug 06, 2021

BUY
$22.3 - $36.02 $13,157 - $21,251
590 Added 3.98%
15,401 $539,000
Q4 2020

Feb 12, 2021

BUY
$10.5 - $28.5 $6,226 - $16,900
593 Added 4.17%
14,811 $384,000
Q3 2020

Nov 13, 2020

BUY
$3.61 - $9.87 $5,346 - $14,617
1,481 Added 11.63%
14,218 $140,000
Q1 2020

May 13, 2020

BUY
$2.36 - $5.26 $3,370 - $7,511
1,428 Added 12.63%
12,737 $39,000
Q1 2019

May 15, 2019

BUY
$6.8 - $7.4 $8,160 - $8,880
1,200 Added 11.87%
11,309 $82,000
Q4 2018

Feb 12, 2019

BUY
$3.99 - $7.82 $5,107 - $10,009
1,280 Added 14.5%
10,109 $75,000
Q4 2017

Feb 14, 2018

BUY
$2.59 - $5.44 $4,902 - $10,297
1,893 Added 27.29%
8,829 $23,000
Q2 2017

Aug 15, 2017

BUY
N/A
6,936
6,936 $25,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.